BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 97.54% institutional investors, 0.89% insiders, and 1.58% retail investors. Blackrock is the largest institutional shareholder, holding 12.04% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 4.68% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical97.54%0.89%1.58%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.74M12.04%$1.87B
Vanguard group18.99M10.06%$1.56B
Primecap management co/ca/18.79M9.95%$1.55B
Dodge & cox13.93M7.38%$1.15B
Capital research global investors9.69M5.13%$798.01M
State street9.64M5.10%$793.33M
Viking global investors lp7.06M3.74%$581.54M
Ameriprise financial4.70M2.49%$387.06M
Avoro capital advisors4.56M2.41%$375.21M
Norges bank3.62M1.92%$297.99M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp1.13M10.78%$93.05M
Saturn v capital management178.59K5.56%$14.70M
Avoro capital advisors4.56M5.00%$375.21M
Eagle health investments lp231.80K3.35%$19.08M
Viking global investors lp7.06M2.23%$581.54M
Novo490.00K2.02%$40.34M
Rhenman & partners asset management ab251.50K1.99%$20.71M
Sector gamma as63.35K1.95%$5.22M
Motley fool wealth management445.70K1.87%$36.71M
Elliott investment management3.50M1.66%$288.18M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank3.62M0.04%3.62M
Capital research global investors9.69M0.18%3.17M
State street9.64M0.03%2.74M
Vanguard group18.99M0.03%876.93K

Top Sellers

HolderShares% AssetsChange
Nomura---1.49M
Point72 asset management---1.35M
Camber capital management lp---1.10M
Parnassus investments---873.00K
Ameriprise financial4.70M0.10%-702.22K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.62M0.04%3.62M$297.99M
Loomis sayles & co l p331.50K0.04%331.50K$27.29M
Corebridge financial240.17K0.11%240.17K$19.77M
Retirement systems of alabama234.36K0.07%234.36K$19.29M
Eagle health investments lp231.80K3.35%231.80K$19.08M

Sold Out

HolderChange
Hexagon capital partners-3.00
Householder group estate & retirement specialist-3.00
Abich financial wealth management-5.00
Financial gravity asset management-7.00
Fortitude family office-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024583-2.35%184,215,3300.81%971.04%28513.55%178-13.17%
Mar 31, 20245973.29%182,743,407-1.16%961.00%251-4.56%2053.02%
Dec 31, 20235787.04%184,894,3974.31%981.11%26314.85%1996.99%
Sep 30, 2023540-8.16%177,258,675-0.14%941.06%229-12.60%186-1.59%
Jun 30, 20235880.51%177,502,540-0.23%941.04%262-2.24%1891.61%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I8.91M4.68%-
Vanguard PRIMECAP Inv7.27M3.81%200.00K
Vanguard Total Stock Mkt Idx Inv6.04M3.17%4.43K
iShares Core S&P Mid-Cap ETF5.99M3.15%3.25K
Vanguard Capital Opportunity Inv5.55M2.91%63.00K
American Funds Growth Fund of Amer A4.97M2.61%389.40K
Capital Group Growth Fnd of Amer Comp4.97M2.61%389.40K
VA CollegeAmerica Amcap 529A4.61M2.42%314.33K
Capital Group AMCAP Composite4.61M2.42%314.33K
Vanguard Mid Cap Index Institutional4.03M2.12%-31.32K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 12, 2024Guyer Charles Greg EVP, Chief Technical OfficerSell$350.32K
Aug 13, 2024Burkhart Erin GVP, Chief Accounting OfficerSell$64.26K
May 30, 2024Mueller Brian EVP, Chief Financial OfficerSell$375.95K
May 28, 2024Davis George Eric EVP, Chief Legal OfficerSell$209.23K
May 28, 2024Davis George Eric EVP, Chief Legal OfficerSell$2.83M

Insider Transactions Trends


DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2-10
2024 Q1-10
2023 Q4-2

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 97.54%, followed by 0.89% insiders and 1.57% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 45.43%, which BioMarin Pharmaceutical exceeds.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock (22.74M shares, 12.04%), Vanguard group (18.99M shares, 10.06%), and Primecap management co/ca/ (18.79M shares, 9.95%). Together, they hold 32.05% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 10.78% of its assets in 1.13M BioMarin Pharmaceutical shares, valued at 93.05M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 4.68% of its total shares outstanding invested in 8.91M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools